论文信息 - Ornithyl amphotericin methyl ester treatment of experimental candidiasis in rats

Ornithyl amphotericin methyl ester treatment of experimental candidiasis in rats

After intravenous Candida albicans infection, rats received orinthyl amphotericin methyl ester, amphotericin B, or diluent intravenously. At doses of 0.1 and 0.5 mg/kg, the drugs were equally effective in preventing deaths. However, at doses of 2.0 mg/kg, mortality after treatment with amphotericin B was greater than that after placebo, whereas orinthyl amphotericin methyl ester was fully protective.

J. Galgiani | D. Vanwyck

[1] B. Wong,et al. Increased arabinitol levels in experimental candidiasis in rats: arabinitol appearance rates, arabinitol/creatinine ratios, and severity of infection. , 1982, The Journal of infectious diseases.

[2] R. Sobel,et al. Leukoencephalopathy in patients treated with amphotericin B methyl ester. , 1982, The Journal of infectious diseases.

[3] J. Utz. Chemotherapy of the systemic mycoses. , 1973, The Medical clinics of North America.

[4] J. Galgiani,et al. Turbidimetric Studies of Growth Inhibition of Yeasts with Three Drugs: Inquiry into Inoculum-Dependent Susceptibility Testing, Time of Onset of Drug Effect, and Implications for Current and Newer Methods , 1978, Antimicrobial Agents and Chemotherapy.

[5] Y. Yoon,et al. Comparative Toxicological Studies of Amphotericin B Methyl Ester and Amphotericin B in Mice, Rats, and Dogs , 1976, Antimicrobial Agents and Chemotherapy.

[6] C. Schaffner,et al. Polyene macrolide derivatives. I. N-acylation and esterification reactions with amphotericin B. , 1972, The Journal of antibiotics.

[7] C. Schaffner,et al. Polyene macrolide derivatives. II. Physical-chemical properties of polyene macrolide esters and their water soluble salts. , 1972, The Journal of antibiotics.